Role of CEUS in the diagnosis of gallbladder disease by Zeno Spârchez & Pompilia Radu
Review Med Ultrason
2012, Vol. 14, no. 4, 326-330
Abstract
Conventional ultrasound (US) is the first imaging investigation recommended for diagnosis of gallbladder pathology. 
However, it has an important limit of ability to depict microcirculation of some biliary lesions which may lead to failure in 
diagnosis. The use of contrast-enhanced US (CEUS) seems to overcome these limits and allows a more confident diagnosis. 
In this review, the methodology, image interpretation, enhancement pattern, clinical usefulness, and indications for CEUS in 
gallbladder lesions are summarized. CEUS may be indicated under the following circumstances: 1) For differentiation diag-
nosis between a malign tumor or a benign tumor of the gallbladder; 2) to make a distinction between motionless sludge and 
gallbladder carcinoma; 3) to assess the extension of gallbladder carcinoma in adjacent hepatic parenchyma; 4) patients with 
impaired renal function.
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Introduction 
B mode ultrasound (US) is the first imaging investi-
gation performed for the diagnosis of biliary pathology. 
It has a high sensitivity to detect gallbladder stones and 
intra-hepatic or extra-hepatic bile duct dilatation. The 
main limitation of ultrasound is a low ability to assess 
vascularity and therefore to establish the nature of gall-
bladder and biliary ducts tumors [1]. 
In generally gallbladder cancers present as either a 
solid mass that occupy the whole gallbladder or a focal 
polypoid lesion on conventional US. Also a motionless 
biliary sludge can generate similar US images with gall-
bladder cancer [2]. In these cases the presence of vessels 
can make the differential diagnosis between a benign le-
sion and gallbladder cancer. Color and power Doppler 
US have been developed to overcome these limitations 
but several limits still remained: a slow flow or deeply 
located blood vessels [1,2]. 
The introduction of micro-bubble contrast agents 
(UCA) and the development of contrast-specific imaging 
techniques have improved the performance of B mode 
US. Microbubble contrast agents have diameters in the 
range of 1–10 mm (median 2 mm) that do not allow  fil-
tering by the lungs or the entering into the interstitial flu-
id. Therefore, they are completely intravascular contrast 
agents. Having this feature they give an accurate assess-
ment of the blood flow within a lesion and  permit the 
diagnosis of the nature of that lesion. Another important 
feature is that micro-bubbles agents are not radioactive. 
SonoVueTM micro- bubbles are composed of a sulphur 
hexafluoride gas with a phospholipids shell. The contrast 
agents are metabolized by the liver and the sulphur hex-
afluoride gas is exhaled via the lungs.
After several studies showed that the utilization of 
contrast-enhanced ultrasound (CEUS) substantially im-
proves the detection and the characterization of gallblad-
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der lesions [2-5], in 2011 CEUS was accepted in the 
Guidelines and good clinical practice recommendations 
for CEUS - update 2011, for  clinical practice [6].
Scanning method
Each patient has to be fasted for least 8 hours before 
examination.  Before performing a CEUS examination, 
the gallbladder and adjacent liver parenchyma should 
be examined using conventional gray-scale US and the 
target lesion identified. After identification of the target 
lesion, the transducer is kept in a stable position and 
the imaging mode is changed to low mechanical in-
dex (MI<0.2). The tissue signals are eliminated and the 
depth, gain and focus are carefully adjusted. UCA is ad-
ministered intravenously through the antecubital vein as 
a bolus (within 1-2 s), followed by a flush of 10 ml 0.9% 
sodium chloride solution. The timer should be activated 
from the beginning of contrast agent administration and 
the lesion is observed intermittently for at least 3 min. It 
is important that the entire CEUS process for the intrahe-
patic biliary system should performed with reference to 
the adjacent liver parenchyma [2].
CEUS – enhancement pattern of gallbladder
The vascular phases of the gallbladder are different 
from those of the liver because the blood supply is pro-
vided entirely by the cystic artery and not by portal vein 
branches. Therefore only 2 phases can be followed: arte-
rial phase (10–20 s after bolus injection) and late phase 
(31–180 s after contrast injection). The late phase persists 
for a short time in comparison with that for the liver [7,8]. 
Enhancement is assessed by comparing the echogenicity 
of a lesion with the echogenicity of the liver parenchyma.
Pathology
1. Polypoid lesions of the gallbladder
The majority of polypoid lesions of the gallbladder 
are cholesterol polyps. US has 90% sensitivity for the de-
tection of polypoid lesions. Distinguishing a potentially 
pre-malignant adenoma from a benign cholesterol polyp 
is not possible always only on the basis of US. There are 
several features that can suggest the benign nature of 
polypoid lesions: size less than 10 mm, multiplicity and 
an increased echogenicity. By contrast, increasing size on 
sequential US examinations, focal thickening of the gall-
bladder wall or nodularity adjacent to a polypoid mass 
can suggest malignancy. 
The US appearance of cholesterol polyps is that of 
multiple, non-shadowing, oval lesions attached to the 
gallbladder wall. The size is usually 2-5 mm and the di-
agnosis is made easily with US. Larger lesions (up to 20 
Fig 1. Cholesterol polyps. a) Conventional US de-
picts one echogenic lesion arising from the gall-
bladder wall (<). b) CEUS image at 15 s after CA 
administration demonstrates vascularity of the le-
sion; c) macroscopic specimen.
Fig 2. Gallbladder adenoma. a) B mode US shows 
an echogenic mass arising from the wall; b) in arte-
rial phase the lesion is isoenhanced in respect with 
the liver; 3) in venous phase the lesion in slightly 
hypoenhanced.
mm) should be differentiated from adenomas or gallblad-
der carcinomas [9].
On CEUS, hyper-enhancement is found in the ma-
jority (93%) of the lesions and the remaining 7% show 
iso-enhancement during the early phase. In cholester-
ol polyps, normal-caliber arteries taper normally and 
subdivide normally into small vessels, thereby the le-
sion shows dotted- or branched-type tumor vessels on 
CEUS. In the late phase, hypo-enhancement is found in 
64% and iso-enhancement in 36% of the lesions [2,7] 
(fig 1).
2. Gallbladder adenomas
Gallbladder adenomas are relatively uncommon, 
with an incidence ranging between 0.3% and 0.5% in 
gallbladders removed [7]. Gallbladder adenoma appears 
on US as a sessile polypoid mass, with an echogenicity 
slightly greater or similar to the liver, with a smooth or 
lobulated surface and a relatively homogeneous internal 
texture, without infiltration to the adjacent tissue. On 
CEUS examination adenomas can appear during the ear-
ly phase homogeneous hyper-enhanced (78%) and iso-
enhanced (22%). In the late phase they appear iso- (56%) 
and hypo-enhanced (44%) [2] (fig 2).
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3. Gallbladder sludge
Gallbladder sludge is a mixture of particulate matter 
and bile that occurs when the solutes in bile precipitate. 
In the differentiation between gallbladder cancer and mo-
tionless biliary sludge CEUS has a sensitivity of 100% 
[2,4]. Because of the lack of vessels in the arterial phase 
the mass will appear non-enhanced.  In the late phase it 
will remain non-enhanced (fig 3).
4. Adenomyomatosis
Adenomyomatosis is a hyperplastic cholecystoses , 
has no malignant potential and may involve the gallblad-
der in a focal, segmental or diffuse form. 
It is relatively commonly found in 1-9% of all chole-
cystectomy specimens and is characterized pathologi-
cally by hyperplasia of the wall with formation of intra-
mural mucosal diverticula (Rokitansky-Aschoff sinuses) 
penetrating into the muscular wall of the gallbladder, 
with or without gallbladder wall thickening. 
On US examination the characteristic feature is the 
comet tail artifact echogenic intramural foci from which 
emanate V-shaped “comet tail” reverberation artifacts. 
Those artifacts represent the unique acoustic signature 
of cholesterol crystals within the lumina of Rokitansky-
Aschoff sinuses [1,7,8,10]. At CEUS examination in the 
arterial phase the gallbladder wall has a characteristic 
“moth-eaten” enhancement: the non affected gallbladder 
wall is normally enhanced and the diverticulum zone will 
not depict contrast enhancement [8,10].
5. Acute cholecystitis
Acute cholecystitis is an inflammation of the gall-
bladder wall typically caused by a calculus obstructing 
the cystic duct. On CEUS examination during the arterial 
phase, enhancement of the gallbladder wall will be seen 
earlier than the enhancement of the adjacent liver paren-
chyma. In the late phase the thickened gallbladder wall 
will have an obvious “wash-out” comparative with the 
liver parenchyma (Figure 4). CEUS examination has an 
important role in detecting abscess formation in the sur-
rounding liver parenchyma. Interruption of the gallblad-
der wall suggests perforation, which can be confirmed 
by the absence of enhancement of the perforated wall 
[2,3,8,6] (fig 5).
6. Gallbladder malignant tumors.
Gallbladder carcinoma is the fifth most common 
malignancy of the gastrointestinal tract and has an as-
sociation with gall stones [8]. On US examination it can 
appear like a polypoid intraluminal lesion, a tissue mass 
infiltrating the gallbladder wall and the surrounding he-
patic parenchyma or a diffuse mural thickening [1,9]. 
On CEUS examination, the arterial branches that sup-
ply the gallbladder carcinoma tend to show irregularly 
tortuous extension. The late phase washout of the con-
trast agent within 35-60 seconds after administration may 
be a key for differential diagnosis [2] (fig 6). Improved 
gallbladder wall visualization following contrast admin-
istration and the malignant feature of late-phase hypovas-
cularity relative to the hepatic parenchyma may provide 
sharp demarcation of tumor outline.
Another appearance that can be seen in gallbladder 
carcinoma is a disruption of the gallbladder wall integ-
Fig 3. Gallbladder sludge. a) B mode US shows 
a gallbladder with an echogenic mass inside; b) 
CEUS in arterial phase depicts no enhancement 
within the mass.
Fig 4. Acute cholecystitis a) B mode US in a pa-
tient after endoscopic stent placement shows a 
thickened , double layer gallbladder wall ; b) in 
arterial phase the wall is hyperenhanced ; c) in 
venous phase the wall becomes slightly hypoen-
hanced.
Fig 5. Acute cholecystitis with perforation and abscess 
formation. a) US shows a gallbladder with thickened 
wall and am irregular anechoic structure in the adja-
cent liver; b) CEUS in arterial phase depicts the hy-
perenhaced wall and a small disruption of the wall (<). 
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rity. On CEUS examination, in the arterial phase the wall 
disruption is better visualized [8] (fig 7).
Metastases to the gallbladder are very rare, the most 
common tumor leading to a metastatic tumor of the gall-
bladder being malignant melanoma. The lesions are usu-
ally multiple, hyperechoic broad base polypoid lesions 
larger then 10 mm [9]. The lesions are hyperenhancing in 
arterial phase with a rapid wash out (fig 8).
7. Difference between benign and malignant lesions.
All gallbladder tumors, benign or malign, are sup-
plied by arterial vessels from branches of the cystic ar-
tery. Therefore in the arterial phase most of the lesions 
are hyper-enhanced in the early phase of CEUS and 
no difference between them  is detected [2,5].  Hyper-
enhancement in the arterial phase was present in 84.8% 
of carcinomas and in 70.2% of benign lesions ( 92.2% 
cholesterol polyps, 77.8% adenomas and 85.5 % chronic 
cholecystitis) [7].
The distribution of the vessels inside the lesion may 
add some diagnostic features. Thus, the benign lesions 
show dotted vessel enhancement whereas malignant le-
sions tortuous vessel enhancement [7].
Although the late phase is important in establishing the 
nature of the hepatic lesion, for gallbladder this algorithm 
is not always applicable. Nevertheless wash-out phenom-
enon of the contrast agent within 35-60 s after UCA ad-
ministration was present mostly in malignant tumors [5].
Disruption of the gallbladder wall integrity appears in 
85% of gallbladder carcinomas and in none of the benign 
lesions (specificity 100%).
The combination of enhancement pattern (hyper-
enhancement or iso-enhancement in the early phase 
with hypo-enhancement within 35 s after contrast agent 
administration) and lesion’s size yield a sensitivity of 
90.9%, specificity of 87.2% and an accuracy of 88.8 % in 
diagnosing malignancy [2].
8. Conclusions
In the diagnosis of gallbladder lesions CEUS over-
comes the limitations of conventional US and allows an 
improved ability in the assessment of intralesional vas-
cularity. CEUS is a safe method that has proved to have 
a high accuracy in the diagnosis of gallbladder lesions. 
Also it has proved to be a trusted tool in differentiating 
malignant and benign tumors. 
In clinical practice CEUS may be used in the follow-
ing settings: 1) For patients with renal impairment for 
whom the use of contrast agents in CT imaging is not 
allowed; 2) To make a differential diagnostic between a 
malign and a benign tumor of gallbladder; 3) To make 
a differential diagnostic between motionless sludge and 
gallbladder carcinoma; 4) To assess the extension of gall-
bladder carcinoma in adjacent hepatic parenchyma. 
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